The FDA stopped short of pulling Essure from the market, but is requiring them to conduct additional studies into the device. Bayer has indicated that since 2002 over 750,000 women have received the implant as a means of birth control. The FDA has received thousands of concerns, complaints and Adverse Event Reports (AERs) regarding it use with injuries that include severe pelvic plain and bleeds that require removal of the device. The litigation as a whole, however, has not fared well, as many of the cases were ruled pre-empted by the device standard set forth in federal law which indicates if the FDA has approved the device, you may not be able to commence an action. In contrast, Bayer has had to spend over a billion dollars settling litigation for women who took Yaz, Yasmin, Ocella, Safyral, Gianvi, and endured injuries such as deep vein thrombosis (DVT), Pulmonary Embolisms (PE), SVT – either superficial venous thrombosis or sagittal venous thrombosis, strokes or death. The case involved a new generation of hormone that caused an increased risk of clots. Women included in the settlement group had injuries contemporaneous with its usage until the label change in April 2012. Any form of birth control has side effects and it is paramount to speak with your doctor about the risks versus potential benefits. If you feel you are suffering from any adverse experience from the product, you should immediately communicate it with your doctor, or if severe enough call 911.
free case evaluation
Biotech Whistleblower Case Settles for Approximately $2 million – Unnecessary ServicesBy Brown, LLC - Press Center on April 11, 2019 4:50 pm
Biotech Whistleblower Case Settles for Approximately $2 million – Unnecessary Services GenomeDx Biosciences, a biotechnology company in San Diego, has settled allegations that it improperly billed Medicare and private insurance companies for unapproved genomic testing. As part of the settlement, GenomeDxRead More
Our Latest News
JTB Law Group Officially Changes Firm Name to Brow...By Brown, LLC - Press Center on November 29, 2018 1:42 pm
JTB Law Group, LLC has officially changed the name of the firm to Brown, LLC and has moved its primary location to 111 Town Square Place, Suite 400, Jersey City, New Jersey 07310. The new space is beautiful Class A
JTB Law Group, LLC has officially changed the name of the firm to Brown, LLC and has moved its primary location to 111 Town Square Place, Suite 400, Jersey City, New Jersey 07310. The new space is beautiful Class A space overlooking Manhattan. The firm offers a wide variety of free consultations on matter such as whistleblower lawsuits, wage and hour lawsuits, catastrophic injuries, mass torts such as IVC filter injuries, pinnacle hip injuries, Taxotere hair loss, essure birth control injuries and much more.
The firm still has the same staff led by Former FBI Special Agent Jason T. Brown.
With the new firm name to Brown, LLC, the great debate is whether to keep the existing blue badge or to move to a new direction like some of the logos featured below.